EUVIMEDEUVIMED entdecken
Crossref

Region specific utility of MRSA nares screening in patients with diabetic foot cultures across the United States

Christina Gearges, Matthew C Davis, Arthur K Chan, Livia M Chase, Bethany A Wattengel, Alan Lesse, Kari A Mergenhagen

American Journal of Infection Control · 2026

DOI: 10.1016/j.ajic.2026.01.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Infection Control, 2026. Verfasst von Christina Gearges und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Infectious Diseases, Veterans Affairs Western New York Healthcare System, Buffalo, NY. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Diabetic Foot, Mass Screening. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) remains a critical pathogen in diabetic foot infections (DFIs), contributing to prolonged hospitalizations, and morbidity. MRSA nares colonization screening has shown utility in the negative predictive (NPV) value of MRSA infections, though its role in DFIs remains under-characterized. METHODS: This retrospective cohort study analyzed 57,213 hospitalized patients with DFIs across 9 U.S. census regions to evaluate implications of MRSA nares screening for DFIs and to assess regional variations in outcomes. NPV was calculated regionally. Multivariable logistic regression assessed independent predictors of 30-day mortality. RESULTS: MRSA wound culture positivity ranged from 16.1-24.3%. NPV ranged from 86.4% (East South-Central region) to 91.7% (West North Central region), with most regions clustering between 88% and 91%. MRSA nares positivity was associated with 38% increased odds of 30-day mortality (OR 1.38, 95%CI 1.23-1.56). CONCLUSIONS: MRSA nares screening demonstrates high NPV across all regions, supporting its role as a valuable tool for de-escalating empiric anti-MRSA therapy in DFIs. Its limited PPV necessitates confirmatory cultures for positive cases. MRSA nares colonization also serves as an independent predictor of short-term mortality, suggesting its potential use in prognostic risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsDiabetic FootMass ScreeningCarrier StateNoseHumansUnited StatesRetrospective StudiesFemaleMaleAgedMiddle AgedAged, 80 and overSurvival Analysis

Stichwörter der Autor:innen

DiabetesDiabetic foot infections

Autor:innen und Institutionen

  • Departments of Infectious Diseases, Veterans Affairs Western New York Healthcare System, Buffalo, NY.
  • Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo, NY.
  • Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo, NY. Electronic address: Kari.Mergenhagen@va.gov.

Zitieren

APA

Gearges, C., Davis, M. C., Chan, A. K., Chase, L. M., Wattengel, B. A., Lesse, A., & Mergenhagen, K. A. (2026). Region specific utility of MRSA nares screening in patients with diabetic foot cultures across the United States. American Journal of Infection Control. https://doi.org/10.1016/j.ajic.2026.01.005

Vancouver

Gearges C, Davis MC, Chan AK, Chase LM, Wattengel BA, Lesse A, et al. Region specific utility of MRSA nares screening in patients with diabetic foot cultures across the United States. American Journal of Infection Control. 2026. doi:10.1016/j.ajic.2026.01.005

BibTeX
@article{Gearges2026,
  author = {Gearges, Christina and Davis, Matthew C and Chan, Arthur K and Chase, Livia M and Wattengel, Bethany A and Lesse, Alan and Mergenhagen, Kari A},
  title = {Region specific utility of MRSA nares screening in patients with diabetic foot cultures across the United States},
  journal = {American Journal of Infection Control},
  year = {2026},
  doi = {10.1016/j.ajic.2026.01.005}
}
Kostenlos starten →